[(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4S,5R)-4-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10R,11S,12aR,14bS)-10-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

Details

Top
Internal ID 1dcfd9d2-af72-4aeb-8c69-99abcfcd58b7
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides > Triterpene glycosides > Triterpene saponins
IUPAC Name [(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4S,5R)-4-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10R,11S,12aR,14bS)-10-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
SMILES (Canonical) CC1C(C(C(C(O1)OC2C(C(COC2OC(=O)C34CCC(CC3C5=CCC6C(C5(CC4)C)(CCC7C6(CC(C(C7(C)CO)OC8C(C(C(C(O8)CO)OC9C(C(C(CO9)O)O)O)O)O)O)C)C)(C)C)O)O)O)O)OC1C(C(C(CO1)O)OC1C(C(CO1)(CO)O)O)O
SMILES (Isomeric) C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@H](CO[C@H]2OC(=O)[C@@]34CC[C@@]5(C(=CC[C@H]6[C@]5(CC[C@@H]7[C@@]6(C[C@@H]([C@@H]([C@@]7(C)CO)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O[C@H]9[C@@H]([C@H]([C@@H](CO9)O)O)O)O)O)O)C)C)[C@@H]3CC(CC4)(C)C)C)O)O)O)O)O[C@H]1[C@@H]([C@H]([C@@H](CO1)O)O[C@H]1[C@@H]([C@](CO1)(CO)O)O)O
InChI InChI=1S/C62H100O30/c1-25-43(87-50-42(77)44(31(69)21-82-50)88-54-47(78)62(80,23-65)24-84-54)37(72)40(75)51(85-25)90-46-36(71)30(68)20-83-53(46)92-55(79)61-14-12-56(2,3)16-27(61)26-8-9-34-57(4)17-28(66)48(58(5,22-64)33(57)10-11-60(34,7)59(26,6)13-15-61)91-52-41(76)38(73)45(32(18-63)86-52)89-49-39(74)35(70)29(67)19-81-49/h8,25,27-54,63-78,80H,9-24H2,1-7H3/t25-,27-,28-,29+,30-,31+,32+,33+,34+,35-,36-,37-,38+,39+,40+,41+,42+,43-,44-,45+,46+,47-,48-,49-,50-,51-,52-,53-,54-,57-,58-,59+,60+,61-,62+/m0/s1
InChI Key CHDOQCJRHIFTIW-YIGVWDMDSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C62H100O30
Molecular Weight 1325.40 g/mol
Exact Mass 1324.62994177 g/mol
Topological Polar Surface Area (TPSA) 472.00 Ų
XlogP -4.00
Atomic LogP (AlogP) -4.86
H-Bond Acceptor 30
H-Bond Donor 17
Rotatable Bonds 15

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of [(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4S,5R)-4-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-3,5-dihydroxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aS,6aR,6aS,6bR,8aR,9R,10R,11S,12aR,14bS)-10-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-11-hydroxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8593 85.93%
Caco-2 - 0.8711 87.11%
Blood Brain Barrier - 0.6500 65.00%
Human oral bioavailability - 0.8143 81.43%
Subcellular localzation Mitochondria 0.8538 85.38%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.8340 83.40%
OATP1B3 inhibitior - 0.2138 21.38%
MATE1 inhibitior - 0.9200 92.00%
OCT2 inhibitior - 0.6250 62.50%
BSEP inhibitior + 0.9696 96.96%
P-glycoprotein inhibitior + 0.7443 74.43%
P-glycoprotein substrate + 0.6389 63.89%
CYP3A4 substrate + 0.7407 74.07%
CYP2C9 substrate - 0.7973 79.73%
CYP2D6 substrate - 0.8649 86.49%
CYP3A4 inhibition - 0.9081 90.81%
CYP2C9 inhibition - 0.8652 86.52%
CYP2C19 inhibition - 0.9198 91.98%
CYP2D6 inhibition - 0.9299 92.99%
CYP1A2 inhibition - 0.9086 90.86%
CYP2C8 inhibition + 0.7751 77.51%
CYP inhibitory promiscuity - 0.9357 93.57%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.5124 51.24%
Eye corrosion - 0.9896 98.96%
Eye irritation - 0.8980 89.80%
Skin irritation - 0.5174 51.74%
Skin corrosion - 0.9392 93.92%
Ames mutagenesis - 0.6470 64.70%
Human Ether-a-go-go-Related Gene inhibition + 0.7790 77.90%
Micronuclear - 0.8700 87.00%
Hepatotoxicity - 0.7750 77.50%
skin sensitisation - 0.9021 90.21%
Respiratory toxicity + 0.5222 52.22%
Reproductive toxicity + 0.9444 94.44%
Mitochondrial toxicity - 0.5750 57.50%
Nephrotoxicity - 0.5599 55.99%
Acute Oral Toxicity (c) III 0.6216 62.16%
Estrogen receptor binding + 0.7619 76.19%
Androgen receptor binding + 0.7566 75.66%
Thyroid receptor binding + 0.6443 64.43%
Glucocorticoid receptor binding + 0.7943 79.43%
Aromatase binding + 0.6727 67.27%
PPAR gamma + 0.8236 82.36%
Honey bee toxicity - 0.6572 65.72%
Biodegradation - 0.7750 77.50%
Crustacea aquatic toxicity + 0.5050 50.50%
Fish aquatic toxicity + 0.9565 95.65%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 98.96% 91.11%
CHEMBL3714130 P46095 G-protein coupled receptor 6 98.88% 97.36%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 98.42% 95.17%
CHEMBL3137262 O60341 LSD1/CoREST complex 95.14% 97.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 93.30% 95.56%
CHEMBL4302 P08183 P-glycoprotein 1 93.00% 92.98%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 92.08% 94.45%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 92.06% 96.77%
CHEMBL4016 P42262 Glutamate receptor ionotropic, AMPA 2 90.22% 86.92%
CHEMBL2007 P16234 Platelet-derived growth factor receptor alpha 88.83% 91.07%
CHEMBL1806 P11388 DNA topoisomerase II alpha 88.06% 89.00%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 87.98% 96.09%
CHEMBL226 P30542 Adenosine A1 receptor 87.85% 95.93%
CHEMBL4187 Q99250 Sodium channel protein type II alpha subunit 87.78% 95.50%
CHEMBL1994 P08235 Mineralocorticoid receptor 87.50% 100.00%
CHEMBL2111367 P27986 PI3-kinase p110-alpha/p85-alpha 87.14% 94.33%
CHEMBL1293294 P51151 Ras-related protein Rab-9A 86.99% 87.67%
CHEMBL1907602 P06493 Cyclin-dependent kinase 1/cyclin B1 86.98% 91.24%
CHEMBL1293249 Q13887 Kruppel-like factor 5 86.10% 86.33%
CHEMBL5608 Q16288 NT-3 growth factor receptor 85.55% 95.89%
CHEMBL241 Q14432 Phosphodiesterase 3A 84.63% 92.94%
CHEMBL253 P34972 Cannabinoid CB2 receptor 84.49% 97.25%
CHEMBL2581 P07339 Cathepsin D 84.47% 98.95%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 84.32% 99.23%
CHEMBL340 P08684 Cytochrome P450 3A4 83.19% 91.19%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 83.13% 94.00%
CHEMBL5163 Q9NY46 Sodium channel protein type III alpha subunit 80.01% 96.90%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
Argania spinosa

Cross-Links

Top
PubChem 101431990
LOTUS LTS0043759
wikiData Q104958670